Newfound Research’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$79K Buy
1,187
+311
+36% +$23K 0.19% 51
2022
Q2
$67K Buy
+876
New +$66.5K 0.14% 100
2022
Q1
– Sell
-1,333
Closed -$98K – 140
2021
Q4
$98K Sell
1,333
-116
-8% -$7.82K 0.12% 97
2021
Q3
$100K Buy
1,449
+429
+42% +$32.6K 0.16% 70
2021
Q2
$86K Buy
1,020
+115
+13% +$9.59K 0.17% 61
2021
Q1
$74K Sell
905
-353
-28% -$30.1K 0.17% 68
2020
Q4
$109K Buy
1,258
+938
+293% +$81.2K 0.28% 74
2020
Q3
$29K Buy
+320
New +$30.9K 0.08% 88

Other funds holding INCY

Newfound Research's INCY Position: Q3 2022 in Review

Newfound Research increased its Incyte (INCY) stake by 36% in Q3 2022, buying an estimated $23K and bringing the position to 1,187 shares worth $79K. The position accounts for 0.19% of the portfolio, ranked #51.

Newfound Research first reported a position in INCY in Q3 2020 and has held it in 8 quarters since. The position peaked at $109K in Q4 2020. 537 funds tracked by Wall St. Rank hold INCY as of Q3 2022.

  • Newfound Research held 1,187 shares of Incyte worth $79K as of Q3 2022.
  • Newfound Research bought 311 Incyte shares in Q3 2022, an estimated $23K.
  • Incyte made up 0.19% of Newfound Research's portfolio in Q3 2022, its #51 holding.
  • Newfound Research first reported a position in Incyte in Q3 2020 and has held it in 8 quarters since.
  • Newfound Research's Incyte position peaked at $109K in Q4 2020.
  • 537 funds tracked by Wall St. Rank held Incyte as of Q3 2022.

Based on Newfound Research's 13F filing for Q3 2022, filed 13 Oct 2022.